Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

The multiple myeloma armamentarium is large and getting larger. That makes treatment choices complex and the cost of ...

Michaela Hagenhofer, general manager, commercial operations at Johnson & Johnson Innovative Medicine, explains J&J’s ...

Spinal cord pain isn't always just muscle strain — it could signal multiple myeloma. Learn the critical symptoms you must not ...

Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.

GSK’s Blenrep is the only B-cell maturation antigen (BCMA)-targeted antibody-drug conjugate for multiple myeloma, offering ...

Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and a part of JSR Life ...

It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely die from the ...

Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic products, today announced the availability of its first Laboratory Developed Test (LDT): GenoPredicta for ...

Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal plasma cells accumulate, they crowd out healthy cells and cause symptoms ...